CALM and Cadena: metamodeling for component-based product-line development von Childs, A., Greenwald, J., Jung, G., Hoosier, M., Hatcliff, J.

Volltext

Characterization of an Aggregation Pheromone in Hylesinus pruinosus (Coleoptera: Curculionidae: Scolytinae) von Shepherd, William P, Sullivan, Brian T, Hoosier, Bradley M, Barrett, Joanne P, Bauman, Tessa A

Volltext

Building Your Own Software Model Checker Using the Bogor Extensible Model Checking Framework von Dwyer, Matthew B., Hatcliff, John, Hoosier, Matthew, Robby

Volltext

Observations of the solar irradiance in the 200-350 nm interval during the ATLAS-1 Mission: A comparison among three sets of measurements-SSBUV, SOLSPEC, and SUSIM von Cebula, R. P., Thuillier, G. O., VanHoosier, M. E., Hilsenrath, E., Herse, M., Brueckner, G. E., Simon, P. C.

Volltext

Lines of H2 in extreme-ultraviolet solar spectra von JORDAN, C., BRUECKNER, G. E., BARTOE, J.-D. F., SANDLIN, G. D., VAN HOOSIER, M. E.

Volltext

Observed Lα profiles for two solar flares: 14∶12 UT 15 June, 1973 and 23∶16 UT 21 January, 1974 von Canfield, Richard C., Van Hoosier, M. E.

Volltext

The quality of life of the limb-threatened patient after lower-extremity revascularization von Bruni, Karen R., Hoosier-Paty, Dawn M., Hoffman, Gretchen T.

Volltext

Lyman-alpha rocket spectra and models of the quiet and active solar chromosphere based on partial redistribution diagnostics von Basri, G. S., Linsky, J. L., Bartoe, J.-D. F., Brueckner, G., van Hoosier, M. E.

Volltext

Phase II Trial of Cisplatin, Gemcitabine, and Bevacizumab As First-Line Therapy for Metastatic Urothelial Carcinoma: Hoosier Oncology Group GU 04-75 von HAHN, Noah M, STADLER, Walter M, ZON, Robin T, WATERHOUSE, David, PICUS, Joel, NATTAM, Sreenivasa, JOHNSON, Cynthia S, PERKINS, Susan M, WADDELL, Mary Jane, SWEENEY, Christopher J

Volltext

Lines of H 2 in extreme-ultraviolet solar spectra von JORDAN, C, BRUECKNER, G. E, BARTOE, J.-D. F, SANDLIN, G. D, VAN HOOSIER, M. E

Volltext

Fluoxetine Versus Placebo in Advanced Cancer Outpatients: A Double-Blinded Trial of the Hoosier Oncology Group von FISCH, Michael J, LOEHRER, Patrick J, KRISTELLER, Jean, PASSIK, Steven, JUNG, Sin-Ho, JIANZHAO SHEN, ARQUETTE, Matthew A, BRAMES, Mary J, EINHORN, Lawrence H

Volltext

Effect of Clopidogrel on Early Failure of Arteriovenous Fistulas for Hemodialysis: A Randomized Controlled Trial von Dember, Laura M, Beck, Gerald J, Allon, Michael, Delmez, James A, Dixon, Bradley S, Greenberg, Arthur, Himmelfarb, Jonathan, Vazquez, Miguel A, Gassman, Jennifer J, Greene, Tom, Radeva, Milena K, Braden, Gregory L, Ikizler, T. Alp, Rocco, Michael V, Davidson, Ingemar J, Kaufman, James S, Meyers, Catherine M, Kusek, John W, Feldman, Harold I, Dialysis Access Consortium Study Group, for the

Volltext

A phase I/II trial of BNC105P with everolimus in metastatic renal cell carcinoma (mRCC) patients: Updated phase I results of the Disruptor-1 trial von Sarantopoulos, John, Dang, Long H., Lauer, Richard C., Starodub, Alexander, Hauke, Ralph J., Galsky, Matt D., Bylow, Kathryn A., Cowey, Charles Lance, Bibby, David C., Kremmidiotis, Gabriel, Doolin, Elizabeth E., Lavranos, Tina C., Iglesias, Jose Luis, Sonpavde, Guru, Logan, Theodore, Hahn, Noah M., Sweeney, Christopher, Hutson, Thomas E.

Volltext

Updated phase I results of a phase I/II trial of BNC105P with everolimus in patients with metastatic renal cell carcinoma (mRCC) von Hutson, Thomas E., Dang, Long H., Lauer, Richard C., Starodub, Alexander, Hauke, Ralph J., Galsky, Matt D., Bylow, Kathryn A., Cowey, Charles Lance, Bibby, David C., Kremmidiotis, Gabriel, Doolin, Elizabeth E., Lavranos, Tina C., Sonpavde, Guru, Logan, Theodore, Hahn, Noah M., Sweeney, Christopher, Sarantopoulos, John

Volltext

Phase I results of a phase I/II trial of BNC105P with everolimus in metastatic renal cell carcinoma (mRCC) patients previously treated with VEGFR tyrosine kinase inhibitors von Hutson, Thomas E., Dang, Long H., Lauer, Richard C., Starodub, Alexander, Hauke, Ralph J., Galsky, Matt D., Bylow, Kathryn A., Logan, Theodore, Cowey, Charles Lance, Bibby, David C., Kremmidiotis, Gabriel, Doolin, Elizabeth E., Lavranos, Tina C., Sonpavde, Guru, Hahn, Noah M., Sweeney, Christopher, Sarantopoulos, John

Volltext

Phase I/II study of a BNC105P/everolimus regimen for progressive metastatic renal cell carcinoma (mRCC) following prior tyrosine kinase inhibitors (Hoosier Oncology Group) von Hutson, Thomas E., Dang, Long H., Lauer, Richard C., Starodub, Alexander, Hauke, Ralph J., Logan, Theodore, Bylow, Kathryn A., Galsky, Matt D., Bibby, David C., Kremmidiotis, Gabriel, Doolin, Elizabeth E., Lavranos, Tina C., Leske, Annabell F., Hahn, Noah M., Sonpavde, Guru, Sweeney, Christopher, Sarantopoulos, John

Volltext

Phase I/II study of BNC105P in combination with everolimus or following everolimus for progressive metastatic renal cell carcinoma following prior tyrosine kinase inhibitors von Hutson, T. E., Sarantopoulos, J., Logan, T., Sonpavde, G., Galsky, M. D., Sweeney, C., Bibby, D. C., Kremmidiotis, G., Doolin, E. E., Hahn, N. M.

Volltext

A phase II study of concurrent pemetrexed and radiation for poor-risk stage III non-small cell lung cancer (NSCLC): Hoosier Oncology Group LUN08-129 von Feliciano, J. L., Hanna, N. H., Fakiris, A., Yu, M., Dugan, W. M., McClean, J., Bufill, J. A., Bhatia, S., Patel, J. D.

Volltext

Intraperitoneal radioactive phosphorus ( 32P) and vaginal brachytherapy as adjuvant treatment for uterine papillary serous carcinoma and clear cell carcinoma: a phase II Hoosier On... von Fakiris, Achilles J., Moore, David H., Reddy, Shailaja R., Look, Katherine Y., Yiannoutsos, Constantin T., Randall, Marcus E., Cardenes, Higinia R.

Volltext

Phase II study of low-dose topotecan in myelodysplastic syndromes: a Hoosier Oncology Group (HOG) study von Vaena, Daniel A, Walker, Paul, Pennington, Kenneth, Stephens, Anthony, Stender, Michael J, Yiannoutsos, Constantin T, Young, Carol, Stoner, Cindy, Cripe, Larry D

Volltext